Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 1999

View Archived Issues

CyDex and Allergan sign Captisol licensing agreement

Metabolic Modulators and Chugai sign drug discovery agreement

LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans

LeukoSite: year-end 1998 highlights

DiagnoCure: Q1 1999 highlights

NeoPharm to collaborate with NCI on cytotoxic cancer ligand

Available for licensing from NIH: use of thymosin alpha1 for wound healing

Aronex initiates phase I/II trial of Atragen in bladder cancer

GVAX prostate cancer vaccine enters additional phase I/II trial

Select Therapeutics submits pre-IND in Canada for anticancer compound

U. Penn team synthesizes novel analogues of Ritalin for treatment of cocaine addiction

Versicor and Pharmacia & Upjohn join forces for development of new oxazolidinones

Phase III trial of Aliminase in ulcerative colitis initiated

Trega's analgesic effective in postoperative pain study

Novel anticonvulsants described by RCT

Neurokinin antagonists from Solvay particularly useful for GI disorders

Apoptosis-inducing peptide discovered at Morinaga Milk

Tularik presents novel compounds with dual antiproliferative and hypolipidemic effects

Peptidomimetic GH secretagogues synthesized under Japanese-U.S. collaboration

New class of potent, selective human glucagon receptor antagonists presented by Merck

Corvas reports design, synthesis and activity of selective peptidomimetic uPA inhibitors

RPR-CMV-423: a promising candidate for treatment of human CMV infection

Selective, orally active beta3-adrenoceptor agonists identified at Merck

Phase Ib trial of NBI-34060 successfully completed by Neurocrine Biosciences

Anti-CMV activity of BDCRB evaluated in newly designed preclinical model

Preclinical results indicate potential value of clevudine in chronic HBV infections

Didox outperforms hydroxyurea in murine AIDS model

Hughes Institute prepares novel NNRTIs useful as microbicidal spermicides

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...